MGFA has partnered with Bionews to feature the “Myasthenia Gravis News” feed on our MGFA website. We are excited to offer the MG Community this insightful and informative news feed that covers many aspects of living with myasthenia – from research and study results to managing MG, helpful tips, and important news from across the MG World.
Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, BioNews seeks the opinion of outside experts for interviews and Q&As.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- My cousins’ love and loyalty remind me to choose connection, not division
by Mark Harrington on February 4, 2026 at 3:00 pmSome days it feels as if the world has slipped its moorings. Around the globe, the news is grim and relentless, and living with myasthenia gravis (MG) can intensify that sense of instability. When your body is unpredictable, outside chaos lands harder. Lately, though, I’ve been doing some reflecting. I come from a large family. The post My cousins’ love and loyalty remind me to choose connection, not division appeared first on Myasthenia Gravis News.
- CAR T-cell therapy offers year-long relief for gMG patients in trial
by Steve Bryson, PhD on February 4, 2026 at 2:30 pmA single course of six once-weekly infusions of Descartes-08, an investigational CAR T-cell therapy, was well tolerated and resulted in sustained clinically meaningful responses in people with generalized myasthenia gravis (gMG). That’s according to final data from the Phase 2b MG-001 clinical trial (NCT04146051), which also showed that the therapy developed by Cartesian Therapeutics improved The post CAR T-cell therapy offers year-long relief for gMG patients in trial appeared first on Myasthenia Gravis News.
- Corticosteroid use in MG raises risk of developing other conditions
by Andrea Lobo on February 3, 2026 at 4:30 pmPeople with myasthenia gravis (MG) who take corticosteroids, especially at higher cumulative doses, face an increased risk of developing other health conditions, according to a study in the U.S. Patients are at risk for conditions including diabetes, infections, and cardiovascular diseases, the researchers found. “Our findings highlight the importance of individualizing therapy for patients with MG, The post Corticosteroid use in MG raises risk of developing other conditions appeared first on Myasthenia Gravis News.
- Guest Voice: I am stronger than my weakness from MG
by Devi Rose Cabañez on February 2, 2026 at 3:00 pm“You will never amount to anything” and “useless” are words that were etched into my mind since I was very young. Difficulty breathing, chewing, swallowing, and speaking are just some of the symptoms I experience every day. Because of these, I once came close to believing those words. Maybe this is all that life has The post Guest Voice: I am stronger than my weakness from MG appeared first on Myasthenia Gravis News.
- I’m learning to live with my MG body in a new way and love it anyway
by Shawna Barnes on February 2, 2026 at 3:00 pmLoving your body is easy advice to give when your body behaves. When it wakes up when you do, moves when you ask, and carries you through the day without protest. But when you live with myasthenia gravis (MG), the relationship you have with your body becomes something far more complicated. It becomes part partnership, The post I’m learning to live with my MG body in a new way and love it anyway appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.